Commercial manufacture of phenisopham typically follows a multi step carbamate forming process in which an aniline derivative is first converted into the corresponding isopropoxyformyl protected amide, then coupled with an ethyl N phenylcarbamate moiety under controlled esterification or phosgenation based conditions. Industrial routes generally rely on readily available intermediates such as isopropyl chloroformate and phenyl substituted carbamoyl chlorides, using acid scavengers and inert solvents to maintain selectivity and suppress side reactions. After condensation, the crude product is purified through crystallization to achieve the required technical grade purity, followed by formulation into herbicidal products.